Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:26 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 417 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Diabetic Ulcers Clear all

Conditions: Diabetic Foot Ulcers
Interventions: ofloxacin, MSI-78; Drug
Lead sponsor: Abeona Therapeutics, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 342 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1994 – 1996
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Diabetic Foot Ulcers, Venous Stasis Ulcer, Pressure Ulcer, Surgical Wound Dehiscence, Burns, Other Types of Chronic Non Healing Wounds
Interventions: NPWT; Device
Lead sponsor: U.S. Wound Registry; Other
Eligibility: Not listed
Enrollment: 50,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 1
States / cities: The Woodlands, Texas

Conditions: Diabetic Foot, Foot Ulcer; Diabetic
Interventions: Offloading, Dressing Application; Device · Procedure
Lead sponsor: Lower Extremity Institute for Research and Therapy; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2015
U.S. locations: 3
States / cities: Canfield, Ohio • Danville, Virginia • Troutville, Virginia

Conditions: Foot Ulcer, Diabetic, Infection
Interventions: Gentamicin Collagen sponge, Placebo; Drug · Other
Lead sponsor: Innocoll; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 524 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Anniston, Alabama • Las Vegas, Nevada

Conditions: Peripheral Arterial Disease, Diabetic Foot, Diabetes Mellitus
Interventions: ABI/WIFI scoring; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Chronic Wound, Burn Wound, Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Chronic, Wound
Interventions: Epiceram Skin Barrier Function, Vaseline Petroleum Jelly; Device · Biological
Lead sponsor: Sashwati Roy; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2034
U.S. locations: 3
States / cities: Pittsburgh, Pennsylvania

Conditions: Lower Extremity Chronic Ulcers in Diabetics
Interventions: CureXcell®, Sham injection; Biological
Lead sponsor: Macrocure Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 285 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 31
States / cities: Glendale, Arizona • Mesa, Arizona • Phoenix, Arizona + 28 more

Conditions: Diabetic Neuropathies, Painful, Diabetic Foot, Diabetic Peripheral Neuropathy
Interventions: Capsaicin Palmitate, Placebo; Drug
Lead sponsor: Carilion Clinic; Other
Eligibility: 25 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Roanoke, Virginia

Conditions: Foot Ulcer, Diabetic
Interventions: Daily use of podimetrics smart-foot mat; Device
Lead sponsor: Podimetrics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 8
States / cities: Phoenix, Arizona • Tucson, Arizona • Castro Valley, California + 5 more

Conditions: Diabetic Foot Ulcer
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Diabetic Foot
Interventions: Not listed
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Diabetic Foot Ulcer
Interventions: NOX1416 and SOC, SOC (Standard of care); Drug · Procedure
Lead sponsor: NOxy Health Products, LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 13
States / cities: Phoenix, Arizona • Tucson, Arizona • Coral Gables, Florida + 9 more

Conditions: Foot Ulcer, Diabetic, Diabetes Complications
Interventions: MRE0094; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 322 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 63
States / cities: Montgomery, Alabama • Bullhead City, Arizona • Phoenix, Arizona + 56 more

Conditions: Diabetes, Foot Ulcer
Interventions: INTEGRA™ Flowable Matrix (Collagen); Drug
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Foot Ulcer, Diabetic
Interventions: Wound Dressing; Device
Lead sponsor: Solventum US LLC; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 6
States / cities: Montgomery, Alabama • Castro Valley, California • Bay Pines, Florida + 3 more

Conditions: Diabetic Foot Ulcers
Interventions: Cardinal Pro +Simultaneous Irrigation (NPWTi), Cardinal Pro (NPWT) Therapy; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 21 Years to 89 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Venous Leg Ulcer, Diabetic Foot Ulcer
Interventions: EscharEx (EX-02 formulation); Drug
Lead sponsor: MediWound Ltd; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 3
States / cities: Tamarac, Florida • Las Vegas, Nevada • Chapel Hill, North Carolina

Conditions: Diabetic Foot
Interventions: Remote foot temperature monitoring system, Enhanced usual care; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 89 Years
Enrollment: 379 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2031
U.S. locations: 4
States / cities: Hines, Illinois • Richmond, Virginia • Seattle, Washington + 1 more

Conditions: Diabetic Foot Ulcer, Foot Ulcer Chronic, DFU, Ulcer Foot, Venous Leg Ulcer (VLU), Venous Leg Ulcer, Venous Ulcer, Leg Ulcers, Ulcer
Interventions: Tri-Membrane Wrap™ DFU, Membrane Wrap™ DFU, Membrane Wrap-Lite™ DFU, Membrane Wrap-Hydro™ DFU, Tri-Membrane Wrap™ VLU, Membrane Wrap™ VLU, Membrane Wrap-Lite™ VLU, Membrane Wrap-Hydro™ VLU; Other
Lead sponsor: BioLab Holdings; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Philidelphia, Pennsylvania

Conditions: Lower Extremity or Diabetic Foot Ulcers, Bacterial Infection
Interventions: Larval Debridement Therapy, Bedside Sharp Debridement; Device · Procedure
Lead sponsor: North Florida Foundation for Research and Education; Other
Eligibility: 21 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 2
States / cities: Gainesville, Florida

Conditions: Diabetic Foot Ulcers
Interventions: Biovance®, Standard of Care, Diabetic Foot Ulcers; Other
Lead sponsor: Alliqua BioMedical, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 10
States / cities: Montgomery, Alabama • Phoenix, Arizona • Fresno, California + 7 more

Conditions: Diabetic Foot Ulcer, Diabetic Foot Ulcer Associated With Type II Diabetes Mellitus
Interventions: Exoskeleton; Device
Lead sponsor: Results Group LLC; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Los Angeles, California • New Haven, Connecticut

Conditions: Foot Ulcer, Diabetic
Interventions: Quantum™ Therapy - NPWT with Prontosan, Quantum™ Therapy; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 21 Years to 89 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Diabetes, Diabetic Foot, Diabetic Foot Ulcer
Interventions: DV-SSP Imaging; Diagnostic Test
Lead sponsor: SpectralMD; Industry
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 11
States / cities: Encino, California • Los Angeles, California • Lake Success, New York + 8 more

Search by objective public record fields.

MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers

Negative Pressure Wound Therapy Registry

Study of Amniotic Membrane Graft in the Management of Diabetic Foot Ulcers

Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers

Implementation of ABI and WIfI in Rural Health Clinics

Wound Healing Endpoint and Recurrence

Evaluation of CureXcell® in Treating Lower Extremity Chronic Ulcers in Adults With Diabetes

Efficacy of a Topical Palmitated Formulation of Capsaicin (Capsadyn®) In the Treatment of Diabetic Neuropathic Foot Pain

In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers

Study to Evaluate Bacterial Activity That Drives the Progression of Clinical Infection

Study of Subjects With Diabetic Foot Ulcer (DFU)

NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers

Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers

Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers

A Comparison of an Investigational Dressing to Tegaderm Matrix Wound Dressing in the Management of Diabetic Foot Ulcers

Negative Pressure Wound Therapy as a Drug Delivery System

A Study to Evaluate the Clinical Performance, Safety and Pharmacology Effect of EscharEx in Patients With Lower Leg Ulcers

Effectiveness of Remote Foot Temperature Monitoring

Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers

Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm

Postmarket Study to Evaluate Biovance® in Diabetic Foot Ulcers

Assistive ExoSkeletons to Enable Wearable Rehabilitation Robotics

Negative Pressure Wound Therapy as a Drug Delivery System (ADANPWT)

Wound Assessment Using Spectral Imaging US